Report on China's Anti-fungal Drug IndustrySunFAITH China Ltd.December 13, 2006 20 Pages - SKU: CJFQ1421805 |
| Countries covered: China The sales scale of anti-fungals in Chinese hospitals has increased stably since 1999. And in 2004, the growth rate of anti-fungals reached as high as 31.16% and the sales value reached RMB 2.172 billion. Fungal infection is generally divided into anti-fungal for superficial infection and anti-fungal for invasive infection, accounting for over 60% share and in recent years the share is nearly 70%. The share of the TOP 5 brands in 2001 was 85.68% and that of TOP 5 brands in 2004 was 89.29%, which indicates the high market concentration of anti-fungal drugs. During 2001 and 2004, fluconazole, itraconazole and terbinafine were in the first three places. Among the TOP 20 manufacturers in market share in 2004, 9 are foreign enterprises and joint ventures and 11 are Chinese enterprises. Pfizer Pharmaceuticals Limited (Pfizer) is always taking the lead and its share is rising increasingly. In 2004, its share was 38.1%, followed by Janssen Pharmaceutical (Xi'an) Ltd (Xi’an Janseen) and Novartis. In view of geographical distribution of the 16 major cities in 2004, the TOP 4 cities are economic developed and populous cities, Shanghai, Beijing, Guangzhou and Hangzhou, which take up for 56.87% of the total share of the 16major cities. In addition, this report detailed describes the TOP 3 anti-fungals’ manufacturers in share and the shares in major cities. Finally, this report also presents anti-fungals’ trading name, formulation, manufacturers and retail price. |
More China Dermatology Reports
China Dermatitis Prescription Drug Sales Data 2006-2010 by
Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...
Medicalised Beauty Market China 2011 by
Diagonal Reports Ltd.
Chinese women want flawless skin and have exacting standards. This pursuit of perfect skin has created a huge market for products and treatments. More recently, ...
Medicated Skin Products in the BRIC (Brazil, Russia, India, China) Countries - Market Overview and Forecasts to 2014 by
Datamonitor
Introduction This report covers key aspects of the medicated skin products market in four emerging / high growth economies: Brazil, Russia, India and China. Data ...
Medicated Skin Care - China by
Euromonitor International
Medicated skin care is one of the most important categories in China’s OTC market, accounting for 21% of total OTC market size. Sales of medicated ...
Chinese Markets for Skin Cancer Treatment Drugs by
Asia Market Information & Development Company
China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Dermatology Reports
- Alopecia Global Clinical Trials Review, H1, 2012
- Botulinum Toxin
- World Market for Prescription Dermatological Drugs, 8th Edition (Antiacne, Antiaging, Dermatitis, Hair Loss, Psoriasis, Skin Cancer, Melasma and Seborrhea Treatments)
- Analytical Tool - Melanoma
- Dermatological Drugs: World Market Prospects 2012-2022
